Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 258-753-8 | CAS number: 53770-52-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- October 2012 - March 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and guideline compliant study, no restrictions
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 treated rat liver S9 fraction
- Test concentrations with justification for top dose:
- Expt 1: 156.25, 312.5, 625, 1250, 2500 and 5000 µg/mL
Expt 2: 187.5, 375, 750, 1500, 3000 and 5000 µg/mL - Vehicle / solvent:
- DMSO
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Remarks:
- Ethyl Methanesulfonate (0.4 µL/mL) was used -S9; and Benzo(a)pyrene (6 µg/mL) was used +S9
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Preincubation period: 24 hours
- Exposure duration: 4 hours
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: 1 x 10^6
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency - Evaluation criteria:
- A test chemical is considered positive in the mutation assay if:
i. A positive result is defined as a concentration-related biologically significant increase in mutant frequency in comparison with concurrent negative control and the test item causes a three-fold increase (Nestmann, E.R. et al., 1991) in the number of 6-thioguanine resistant colonies relative to concurrent negative control and such increases are statistically significant and outside of the laboratory historical negative (solvent used) control range.
ii. A net increase in mutant colonies of treated above the concurrent control is observed in at least two of the concentrations tested.
Negative results were confirmed by a repeat test (short duration), using a modification in test concentrations. - Statistics:
- Weighted regression analysis was performed to evaluate the dose response relationship (Li, A.P. et al., 1987; Hsie, A.W. et al., 1981) on zinc 3,5-bis(α-methylbenzyl)salicylate treatment groups against negative control (excluding positive controls).
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative
From these results, it is concluded that zinc 3,5-bis(α-methylbenzyl)salicylate does not have potential to induce gene mutations at the hgprt locus of CHO-K1 cells, both in the absence and presence of metabolic activation under the present experimental conditions. - Executive summary:
The mutagenic potential of zinc 3,5-bis(α-methylbenzyl)salicylate was assessed both in the absence and presence of metabolic activation using the CHO-K1 cell line. Zinc 3,5-bis(α-methylbenzyl)salicylate was tested in two independent experiments, with and without metabolic activation. Ethyl methanesulfonate (0.4 µL/mL) and benzo(a)pyrene (6 µg/mL) were used as the positive control in the absence and presence of metabolic activation, respectively.
The CHO-K1 cells were exposed to zinc 3,5-bis(α-methylbenzyl)salicylate at the test concentrations of ranging from 156.25, to 5000 µg/mL both in the absence and presence of metabolic activation for a period of 4 hours.
No significant dose-related effect was observed at any of the treated concentrations during either trial of the experiments.
No relevant influence of the test item on pH value or osmolality was observed. The spontaneous mutation level was (negative control) within the acceptable limit in both the trials, validating the acceptability of the test system. The increased mutant frequency observed in positive controls demonstrated the efficiency of the test system and suitability of the test procedures and conditions employed in the study.
From these results, it is concluded that zinc 3,5-bis(α-methylbenzyl)salicylate does not have potential to induce gene mutations at thehgprtlocus of CHO-K1 cells both in the absence and presence of metabolic activation under the present experimental conditions.
Reference
Absolute Cloning Efficiency at Selection and Mutant Frequency
The mean absolute cloning efficiency (ACE) at selection and mean mutation frequency per 1 x 106cells (MF) in the absence and presence of metabolic activation for trial I and trial II are provided below:
Group (µg/mL) |
TRIAL I |
Group (µg/mL) |
TRIAL II |
||||||
- S9 |
+ S9 (2% v/v S9) |
- S9 |
+ S9 (2% v/v S9) |
||||||
Mean ACE |
Mean MF |
Mean ACE |
Mean |
Mean ACE |
Mean |
Mean ACE |
Mean |
||
NC (DMSO) |
0.8286 |
9.36 |
0.7570 |
9.57 |
NC (DMSO) |
0.7830 |
13.31 |
0.7562 |
16.03 |
T1 (156.25) |
0.7811 |
8.54 |
0.7411 |
8.70 |
T1 (187.5) |
0.7403 |
15.85 |
0.7482 |
12.28 |
T2 (312.5) |
0.7227 |
10.31 |
0.7279 |
12.93 |
T2 (375) |
0.7215 |
13.88 |
0.7331 |
15.27 |
T3 (625) |
0.6721 |
13.44 |
0.6706 |
14.60 |
T3 (750) |
0.7170 |
14.53 |
0.7510 |
13.20 |
T4 (1250) |
0.6813 |
12.45 |
0.7243 |
9.23 |
T4 (1500) |
0.6970 |
14.59 |
0.6879 |
15.91 |
T5 (2500) |
0.6740 |
9.64 |
0.6188 |
10.85 |
T5 (3000) |
0.6780 |
12.55 |
0.6299 |
16.14 |
T6 (5000) |
0.4964 |
13.53 |
0.5339 |
17.26 |
T6 (5000) |
0.5248 |
14.65 |
0.5249 |
17.06 |
PC |
0.5282 |
221.88 |
0.5351 |
221.46 |
PC |
0.5391 |
236.03 |
0.5536 |
201.95 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
In vitro mammalian cell gene forward mutation test at the hgprt locus of the Chinese hamster ovary (CHO)-K1 cell line using zinc 3,5-bis(α-methylbenzyl)salicylate: From these results, it is concluded that zinc 3,5-bis(α-methylbenzyl)salicylate does not have potential to induce gene mutations at the hgprt locus of CHO-K1 cells, both in the absence and presence of metabolic activation under the present experimental conditions.
Mixture containing 30.2% zinc 3,5-bis(alpha-methylbenzyl)salicylate: Reverse Mutation Assay ''Ames Test'' Using Salmonella Typhimurium Project Number 318/38: The mixture was found to be non-mutagenic under the conditions of this test.
Mixture containing 30.2% zinc 3,5-bis(alpha-methylbenzyl)salicylate: Metaphase Analysis In Human Lymphocytes In Vitro Project Number 318/39: The mixture produced no significant increases in the frequency of chromosome aberrations either in the presence or absence of a liver enzyme metabolising system; this mixture is therefore considered to be non-clastogenic to human lymphocytes in vitro.
Justification for read-across
Two of the three studies described above were conducted using a liquid mixture containing 30.2% zinc 3,5-bis(alpha-methylbenzyl)salicylate.
The remaining substances present in the mixture include:
- 5.5% PSMS-11
- 1.1% PVA
- 0.7% DIBLAME
- < 1% Other
- Remainder: water
PSMS-11 and PVA are not considered to be hazardous substances. DIBLAME is classified as H315: Causes skin irritation, H317: May cause an allergic skin reaction and H411: Toxic to aquatic life with long lasting effects. However, the concentration of DIBLAME in the mixture is below that which triggers classification of the mixture for these hazards. Therefore, it is considered justified to read-across from this mixture to zinc 3,5-bis(α-methylbenzyl)salicylate.
Justification for selection of genetic toxicity endpoint
Only study categorised as Klimisch 1.
Justification for classification or non-classification
The above studies have been ranked reliability 1 or 2 according to the Klimisch et al system. This ranking was deemed appropriate because these studies are conducted according to recognised test methods. Sufficient dose ranges and numbers are detailed; hence they are appropriate for use based on reliability and animal welfare grounds.
The above results triggered no classification in accordance with the CLP Regulation (EC No 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
